DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Morrow DA, Scirica BM, Fox KAA et al.
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.
Am Heart J 2009;
158
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.